196 related articles for article (PubMed ID: 19661169)
1. Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study.
Kassner A; Roberts TP; Moran B; Silver FL; Mikulis DJ
AJNR Am J Neuroradiol; 2009 Nov; 30(10):1864-9. PubMed ID: 19661169
[TBL] [Abstract][Full Text] [Related]
2. Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke.
Wu S; Thornhill RE; Chen S; Rammo W; Mikulis DJ; Kassner A
Invest Radiol; 2009 Oct; 44(10):662-8. PubMed ID: 19724234
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
Larrue V; von Kummer R R; Müller A; Bluhmki E
Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
[TBL] [Abstract][Full Text] [Related]
4. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
6. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
Jucevičiūtė N; Mikužis P; Balnytė R
BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
[TBL] [Abstract][Full Text] [Related]
7. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
Dong X; Nao J; Gao Y
Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
[TBL] [Abstract][Full Text] [Related]
9. Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan?
Vidarsson L; Thornhill RE; Liu F; Mikulis DJ; Kassner A
Magn Reson Imaging; 2009 Nov; 27(9):1216-22. PubMed ID: 19695816
[TBL] [Abstract][Full Text] [Related]
10. [Multi-mode MRI-based intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) reduces hemorrhagic transformation in ischemic stroke patients].
Lin YH; Lou M; Zhu RY; Yan YQ; Zhen ZC; Ding MP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 41(6):665-71. PubMed ID: 23239659
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation.
Thornhill RE; Chen S; Rammo W; Mikulis DJ; Kassner A
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1015-22. PubMed ID: 20190209
[TBL] [Abstract][Full Text] [Related]
12. CT perfusion identifies increased salvage of tissue in patients receiving intravenous recombinant tissue plasminogen activator within 3 hours of stroke onset.
Silvennoinen HM; Hamberg LM; Lindsberg PJ; Valanne L; Hunter GJ
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1118-23. PubMed ID: 18403559
[TBL] [Abstract][Full Text] [Related]
13. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
14. Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke.
Horsch AD; Dankbaar JW; van der Graaf Y; Niesten JM; van Seeters T; van der Schaaf IC; Kappelle LJ; Velthuis BK;
Neuroradiology; 2015 Dec; 57(12):1219-25. PubMed ID: 26337766
[TBL] [Abstract][Full Text] [Related]
15. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.
Adeoye O; Hornung R; Khatri P; Kleindorfer D
Stroke; 2011 Jul; 42(7):1952-5. PubMed ID: 21636813
[TBL] [Abstract][Full Text] [Related]
17. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
[TBL] [Abstract][Full Text] [Related]
18. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
19. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
Simpkins AN; Dias C; Leigh R;
Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
[TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
